Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials. [PDF]
Cohen JA +15 more
europepmc +1 more source
The Unwavering Realism - A comparative case study of modern time security [PDF]
Angenfelt, Christopher
core
In Vivo Evaluation of Nose-to-Brain Delivery of Liposomal Donepezil, Memantine, and BACE-1 siRNA for Alzheimer's Disease Therapy. [PDF]
Lee D +4 more
europepmc +1 more source
Excitotoxic neuronal death requires superoxide entry into neurons through volume-regulated anion channels. [PDF]
Harris K +10 more
europepmc +1 more source
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial. [PDF]
Sands BE +16 more
europepmc +1 more source
Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review. [PDF]
Doumar H +4 more
europepmc +1 more source
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data. [PDF]
Balzano N +9 more
europepmc +1 more source
Late Oligocene Warming Event in the southern North Sea Basin: benthic foraminifera as paleotemperature proxies [PDF]
Anderson +39 more
core +1 more source
Fluorinated HIV-1 protease inhibitors containing chiral hydroxyethylbenzene and indanol as P2' ligands with potent activity against drug-resistant variants. [PDF]
Kaur J +10 more
europepmc +1 more source

